IP Library Granted Patent US 10,086,025
Granted Patent B2
US 10,086,025 · App. 15/626,971 · Granted Oct 2, 2018

Method of identifying a biologically-active composition from a biofilm

Inventors: Eva A. Berkes (Sarasota, FL); Nicholas T. Monsul (Sarasota, FL); Frederick T. Boehm (Sarasota, FL)
Assignee: QUORUM INNOVATIONS, LLC
A61K35/747A01N63/02A61K8/34A61K8/67A61K8/97A61K8/981A61K8/988A61K8/99A61K9/007A61K9/0014A61K9/0043A61K9/0046A61K9/0048A61K35/644A61K35/74A61K35/744A61K39/092A61K45/06A61K47/10A61Q11/00A61Q17/005A61Q19/007A61Q19/10C12N1/20C12Q1/04C12Q1/18A61K36/61A61K2300/00A61K2800/78A61K2800/782G01N2333/315G01N2333/335Y02A50/473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,086,025
App. No.
15/626,971
Granted
Oct 2, 2018
Kind
B2
Abstract

The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3.

Claims (7)

1. An inhaler device containing a biologically-active composition, wherein the biologically-active composition is obtained by a method comprising the steps of:

(a) growing biofilm cellular mass, which has biological activity, in a biological growth medium;

(b) rendering said biofilm cellular mass non-viable; and

(c) combining said non-viable biofilm cellular mass with a carrier that is appropriate for inhalation.

2. The composition, according to claim 1 , wherein the biological activity of said biofilm cellular mass is anti-microbial activity or anti-inflammatory activity.

3. An inhaler device containing a composition comprising non-viable biologically-active biofilm cellular mass.

4. The composition, according to claim 3 , wherein the biological activity of said biofilm cellular mass is anti-microbial activity and/or anti-inflammatory activity.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2025
From: QUORUM INNOVATIONS, LLC
To: QUORUM INNOVATIONS, INC.
Reel/Frame 072547/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2017
From: BERKES, EVA A.; MONSUL, NICHOLAS T.; BOEHM, FREDERICK T.
To: QUORUM INNOVATIONS, LLC
Reel/Frame 042754/0504 →
Continuity (8)
Continuation 15484842 · Apr 11, 2017
Continuation 15412712 · Jan 23, 2017
Continuation 15349371 · Nov 11, 2016
Continuation 15349420 · Nov 11, 2016
Continuation 13503325 · May 31, 2012
Continuation 13503325
Provisional Application 61447735 · Mar 1, 2011
Related Publication 20170281699A1 · Oct 5, 2017
Cited By (1)
US 12,342,826